Aug 18,2021

HIMSS21: Adventist Health Shares How CancerIQ Fueled Systemwide Adoption of Genomics

New integrated technology from CancerIQ is accelerating the lifesaving ripple effect of the Adventist Health Early All-Around Detection (AHEAD) Program, an effort to help patients understand cancer risk for early detection and prevention. In an August 13th session at the HIMSS Global Health Conference in Las Vegas, AHEAD Medical Director Candace Westgate, DO, explained how this technology helped Adventist Health bring genomics to patients in care settings across the health system.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Aug 26,2021

Cancer survivors’ greatest challenges of living with an ostomy: findings from the Ostomy Self-Management Telehealth (OSMT) randomized trial

An ostomy results in lifelong quality of life changes for a cancer survivor. The study describes the greatest challenges reported from a randomized trial of cancer survivors with stomas (ostomies). Cancer survivors with ostomies participating in a multi-site randomized prospective trial of an Ostomy Self-Management Telehealth (OSMT) program versus usual care (UC) were surveyed at six months post accrual.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
Aug 31,2021

An online Sexual Health and Rehabilitation eClinic (TrueNTH SHAReClinic) for prostate cancer patients: a feasibility study

The primary objective of the study was to determine the feasibility of implementing the TrueNTH SHAReClinic - a free, online healthcare clinic focused on helping to cope with the sexual side-effects of prostate cancer - as a pan-Canadian sexual health and rehabilitation intervention for patients treated for localized prostate cancer.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
Aug 31,2021

The Top 12 Health Chatbots Features a Cancer Mobile App Chatbot OneRemisson

New York-based OneRemission launched its chatbot with the aim to help ease the life of those involved in the fight against cancer with the information they need. For cancer patients and cancer survivors, the app empowers them by providing a comprehensive list of diets, exercises, and post-cancer practices, curated by Integrative Medicine experts, so that they don’t need to constantly rely on a doctor.

PRODUCT

#chatbot

View Analyst & Ambassador Comments
Go to original news
Aug 01,2021

Flatiron Health and Unlimited Systems Announce Partnership

Flatiron Health is partnering with Unlimited Systems to deliver best-in-class practice management solutions to the community oncology practices that belong to the Flatiron HC™ network. During the next two years, Flatiron will replace its OncoBilling® practice management system with Unlimited’s Financials system for both existing and new customers.

COLLABORATION PARTNERSHIP

#product & service

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 20,2021

OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced it has been awarded this year’s Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by global growth strategy consulting and research firm Frost & Sullivan. The award recognizes a company that has introduced technology for achieving remarkable product and customer success while driving future business value.

View Analyst & Ambassador Comments
Go to original news
Aug 26,2021

Jasper Health and BioIntelliSense Form Strategic Collaboration to Transform Remote Monitoring for Oncology Care

Jasper Health, an emerging leader of digital engagement for people diagnosed with cancer, today announced it has formed a strategic collaboration with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to integrate its medical grade multi-parameter wearables and data services into Jasper Health’s remote member guidance platform. This unique combination provides a first-of-its-kind remote care offering for cancer patients and their caregivers in managing and supporting complex care needs for those newly diagnosed, currently in treatment and throughout recovery.

COLLABORATION PARTNERSHIP

#connected device

#rpm

View Analyst & Ambassador Comments
Go to original news
Aug 30,2021

Novartis presents important overall survival and quality-of-life results across solid tumor portfolio, among other key data at ESMO

Novartis will present new data from its robust portfolio and pipeline of advanced therapeutic platforms in solid tumors, with more than 55 abstracts from Novartis-sponsored and investigator-initiated trials accepted at the upcoming European Society for Medical Oncology (ESMO) Congress 2021. The ESMO Congress will be held virtually September 16-21, 2021.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 31,2021

Veterans Prostate Cancer Awareness Partnership – Massive Bio

Massive Bio today announced it has entered a partnership with Veterans Prostate Cancer Awareness (VPCa), and Self-Care Catalysts to increase clinical trial and real-world evidence research participation in prostate cancer. This will help put Massive Bio in a position to attract new patients and will provide Veterans Prostate Cancer Awareness and Self-Care Catalysts with new ways to help their members fight cancer.

COLLABORATION PARTNERSHIP

#institution

#rwe

View Analyst & Ambassador Comments
Go to original news
Sep 16,2021

Kaiku Health, Oulu University Hospital and Vaasa Central Hospital to present research at ESMO Congress 2021

Kaiku Health, together with Oulu University Hospital and Vaasa Central Hospital, presents research at the virtual ESMO Congress 2021. The research investigates how ePRO follow-up affects patient care of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy. The poster will be presented at the ESMO Virtual Congress 2021 from September 16th to September 21st on the Congress platform.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY